Carolyn Nakisige

Biographic Data

ID7756725
NAMECarolyn Nakisige
GIVEN NAMESCarolyn
FAMILY NAMENakisige
SIGNATURENAKISIGE C
AFFILIATIONSUganda Cancer Institute
ORCID0000-0002-1497-8056
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS0
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Efficient high-risk human papillomavirus screening through pooled testing

    Open AccessFengming Pan, Marcel JW Greuter et al.ARTICLEJournal of Global Health2026

    Background: The World Health Organization recommends high-risk human papillomavirus (hrHPV) testing as the primary method for cervical cancer screening. Combining samples in a pool can reduce the expense associated with large numbers of commercially available tests. This study simulated the potential test-saving impact of pooled hrHPV testing using real-world data from two low- and middle-income countries (LMICs). Methods: We simulated a two- and…

  • Assessing differences in healthcare access by HIV status to inform cervical cancer and HIV screening in rural Uganda

    Open AccessMia Sheehan, Hallie Dau et al.ARTICLEPLOS Global Public Health2025

    Uganda has one of the highest incidence rates of cervical cancer in the world. Although this impacts all women, women living with human immunodeficiency virus (HIV) experience an increased risk for developing cervical cancer. This study aims to compare how HIV-positive and HIV-negative women in a remote sub-county in Uganda access health services to inform consideration of potential HIV and HPV-based cervical cancer screening integration at the c…

  • High-risk human papillomavirus testing for underscreened populations

    Open AccessMarat Sultanov, Geertruida H de Bock et al.ARTICLEBMC Public Health2025

    The provided estimates can serve to inform policymakers and researchers in the context of implementing hrHPV-based screening in diverse settings

  • The economic burden of cervical cancer on women in Uganda

    Open AccessHallie Dau, Esther Nankya et al.ARTICLEPLOS Global Public Health2024

    There is limited research on how a cervical cancer diagnosis financially impacts women and their families in Uganda. This analysis aimed to describe the economic impact of cervical cancer treatment, including how it differs by socio-economic status (SES) in Uganda. We conducted a cross-sectional study from September 19, 2022 to January 17, 2023. Women were recruited from the Uganda Cancer Institute and Jinja Regional Referral Hospital, and were e…

  • Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda

    Open AccessMarat Sultanov, Jurjen van der Schans et al.ARTICLEJournal of Global Health2024

    Background: Uganda has a high burden of cervical cancer and its current coverage of screening based on visual inspection with acetic acid (VIA) is low. High-risk HPV (hrHPV) testing is recommended by the World Health Organization as part of the global elimination strategy for cervical cancer. In this context, country-specific health economic evaluations can inform national-level decisions regarding implementation. We evaluated the recommended hrH…

  • Investigating feasibility of 2021 WHO protocol for cervical cancer screening in underscreened populations

    Open AccessMarat Sultanov, Janine de Zeeuw et al.ARTICLEBMC Public Health2022

    ClinicalTrials.gov, NCT05234112 . Registered 10 February 2022

  • Integrated cervical cancer screening in Mayuge District Uganda (Aspire Mayuge)

    Open AccessCarolyn Nakisige, Jessica Trawin et al.ARTICLEBMC Public Health2020

    ISRCTN, ISRCTN12767014. Registered 14 May 2019, https://doi.org/10.1186/ISRCTN12767014; clinicaltrials.gov, NCT04000503; Registered 27 June 2019, https://clinicaltrials.gov/ct2/show/NCT04000503 PROTOCOL VERSION: January 8, 2020, version 1